NICOLE LAVERGNE: Open Payments
NPI 1811319114 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 8 payments from 6 companies in 2025. Trend: 2023 $272 · 2024 $485 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $50 |
| ABBVIE INC. | 1 | $29 |
| Noven Therapeutics, LLC | 1 | $18 |
| SCPHARMACEUTICALS INC. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: Wegovy, VRAYLAR, Xelstrym, FUROSCIX, CAPLYTA, ONZETRA XSAIL.
Industry payments across LA — which companies pay providers there.
